Objective: To determine whether management guidelines for infants born extremely preterm are representative for those infants <25 weeks' gestation.
Study design: Three guidelines were reviewed: the 2022 European Consensus Guidelines on the Management of Respiratory Distress Syndrome, the 2017 American Academy of Pediatrics Guidelines for Perinatal Care, and the 2020/21 International Liaison Committee on Resuscitation guidelines. All referenced studies for overlapping recommendations were reviewed. Data extracted included the total number and proportion of infants <25 weeks' gestation in the original articles referred in the guidelines. Where the exact number of infants <25 weeks' gestation was unobtainable, this was conservatively estimated by statistical deduction.
Results: Eight recommendations were included in two or more guidelines: 1) antenatal corticosteroids, 2) antenatal magnesium sulphate, 3) delayed cord clamping, 4) thermoregulation at birth, 5) initial oxygen concentration at birth, 6) continuous positive airway pressure, 7) surfactant, and 8) parenteral nutrition. 519 studies (n=409,986) informed these 8 recommendations, of which 335 (64.5%) were randomized controlled trials (RCTs) (n=78,325). Across all studies, an estimated 59,360 (14.5%) infants were <25 weeks' gestation. Within RCTs alone, an estimated 5,873 (7.5%) infants were <25 weeks' gestation. 196 (37.8%) studies did not include any infants <25 weeks' gestation.
Conclusions: Infants born <25 weeks' gestation are not well-represented in the evidence used to develop major clinical guidelines for infants born extremely preterm . Future studies should provide evidence for this population as a distinct cohort.
Keywords: border of viability; intensive care; neonatology.
Copyright © 2024 Elsevier Inc. All rights reserved.